Apollo Medical Holdings, Inc. today announced that effective on January 23, 2024, the Compensation Committee of ApolloMed’s Board of Directors (the “Committee”) granted 85,130 shares of time-based restricted common stock and 65,265 shares of performance-based restricted common stock to Dinesh M. Kumar, M.D., the Company’s newly-hired Chief Medical Officer, under the Apollo Medical Holdings, Inc. Employment Inducement Award Plan (the “Inducement Plan”).
January 24, 2024
· 3 min read